Email Updates

You are here

A Leap Forward For the Dapivirine Vaginal Ring, the Next Steps Are Critical

September 17, 2020

Px Pulse Logo

In this episode of Px Pulse, the Dapivirine Vaginal Ring is center stage. After decades of research and advocacy, the ring is now one step closer to becoming available as a discreet, woman-initiated HIV prevention option. In July the European Medicines Agency (EMA) issued a positive opinion for the ring, allowing the next steps in the regulatory process to go forward.

Download this podcast to hear five different perspectives on the ring, how it expands HIV prevention options for women, and the most important next steps to bring the ring to women who need it.

Zeda Rosenberg, founder and chief executive officer of the International Partnership for Microbicides (IPM), the ring’s developer, talks about how researchers, implementers and advocates must come together, and the earliest timeline for ring rollout. Cleopatra Makura, a 2019 AVAC Fellow and HIV prevention youth advocate leader in Zimbabwe, talks about what policy makers and young women need for the ring to reach those who need it most. Sharon Hillier, head of the Microbicide Trials Network (MTN), and Benny Kottiri, Research Division Chief in the Office of HIV/AIDS at USAID, remind us what’s remarkable about the ring and underscore the importance of investing in ring introduction and access. And Lori Heise, Professor of Social Epidemiology researcher at the Johns Hopkins Bloomberg School of Public Health and early champion of microbicide research draws lessons from the past that cannot be ignored.